ALMSVSSBFM• 12 Months (Normalized)
ALMS vs SBFM (Alumis Inc. vs Sunshine Biopharma Inc.)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ALMS Performance $8.4
+91.78%
Alumis Inc.
Normalized Baseline0.00%
SBFM Performance $1.03
-93.04%
Sunshine Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin ALMS LEADS
+184.82%
ALMS outperforming by 184.82%
ALMSSBFM
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ALMS SBFM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ALMS Price | ALMS Gain (%) | SBFM Price | SBFM Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $8.40 | +91.78% | $1.03 | -93.04% | +184.82% |
| Sep 14, 2026 | $9.22 | +110.50% | $1.07 | -92.77% | +203.27% |
| Sep 11, 2026 | $9.18 | +109.59% | $1.06 | -92.84% | +202.43% |
| Sep 10, 2026 | $9.90 | +126.03% | $1.08 | -92.70% | +218.73% |
| Sep 09, 2026 | $9.80 | +123.74% | $1.12 | -92.43% | +216.17% |
| Sep 08, 2026 | $10.58 | +141.55% | $1.15 | -92.23% | +233.78% |
| Sep 04, 2026 | $11.10 | +153.42% | $1.14 | -92.30% | +245.72% |
| Sep 03, 2026 | $11.36 | +159.36% | $1.11 | -92.50% | +251.86% |
| Sep 02, 2026 | $10.35 | +136.30% | $1.17 | -92.09% | +228.39% |
| Sep 01, 2026 | $9.47 | +116.21% | $1.13 | -92.36% | +208.57% |
| Aug 31, 2026 | $21.81 | +397.95% | $1.12 | -92.43% | +490.38% |
| Aug 28, 2026 | $22.38 | +410.96% | $1.15 | -92.23% | +503.19% |
| Aug 27, 2026 | $23.21 | +429.91% | $1.27 | -91.42% | +521.33% |
| Aug 26, 2026 | $23.62 | +439.27% | $1.24 | -91.62% | +530.89% |
| Aug 25, 2026 | $23.96 | +447.03% | $1.14 | -92.30% | +539.33% |
Page 1 of 17